Gaugaz, Fabienne Zdenka; Chicca, Andrea; Redondo-Horcajo, Mariano; Barasoain, Isabel; Díaz, J Fernando; Altmann, Karl-Heinz (2019). Synthesis, Microtubule-Binding Affinity, and Antiproliferative Activity of New Epothilone Analogs and of an EGFR-Targeted Epothilone-Peptide Conjugate. International journal of molecular sciences, 20(5) MDPI 10.3390/ijms20051113
|
Text
Synthesis.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (1MB) | Preview |
A new simplified, epoxide-free epothilone analog was prepared incorporating an N-(2-hydroxyethyl)-benzimidazole side chain, which binds to microtubules with high affinity and inhibits cancer cell growth in vitro with nM potency. Building on this scaffold, a disulfide-linked conjugate with the purported EGFR-binding (EGFR, epidermal growth factor receptor) peptide GE11 was then prepared. The conjugate retained significant microtubule-binding affinity, in spite of the size of the peptide attached to the benzimidazole side chain. The antiproliferative activity of the conjugate was significantly lower than for the parent scaffold and, surprisingly, was independent of the EGFR expression status of cells. Our data indicate that the disulfide-based conjugation with the GE11 peptide is not a viable approach for effective tumor-targeting of highly potent epothilones and probably not for other cytotoxics.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Biochemistry and Molecular Medicine |
UniBE Contributor: |
Chicca, Andrea |
Subjects: |
500 Science > 570 Life sciences; biology 600 Technology > 610 Medicine & health |
ISSN: |
1661-6596 |
Publisher: |
MDPI |
Language: |
English |
Submitter: |
Barbara Franziska Järmann-Bangerter |
Date Deposited: |
27 Sep 2019 12:37 |
Last Modified: |
07 Aug 2024 15:45 |
Publisher DOI: |
10.3390/ijms20051113 |
PubMed ID: |
30841526 |
Uncontrolled Keywords: |
cancer drug discovery epothilone medicinal chemistry microtubule-stabilizing agents prodrug total synthesis tumor-targeting |
BORIS DOI: |
10.7892/boris.133499 |
URI: |
https://boris.unibe.ch/id/eprint/133499 |